PRIMARY STUDY

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

Key Findings:  This overview covers the most recent understanding of the pharmacokinetics and novel mechanisms of action of non-psychoactive cannabinoids. There is evidence of the positive effects of cannabidiol in treating inflammation, diabetes, cancer, and neurodegenerative diseases. Additional attention is paid to Delta(9)-tetrahydrocannabivarin, a CB1 antagonist having possible usefulness in treating epilepsy and obesity.